TOCILIZUMAB
tocilizumab 80 mg/4 mL injection, 4 mL vial
TOCILIZUMAB (13311N)
13311N
Manner of administration:Injection
Restriction (Streamlined authority code: 17713)
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 5 | DPMQ: $177.30 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Actemra | |||||